These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24425758)

  • 1. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.
    Wadosky KM; Rodríguez JE; Hite RL; Min JN; Walton BL; Willis MS
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E723-39. PubMed ID: 24425758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
    Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
    Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun.
    Li HH; Du J; Fan YN; Zhang ML; Liu DP; Li L; Lockyer P; Kang EY; Patterson C; Willis MS
    Am J Pathol; 2011 Mar; 178(3):1043-58. PubMed ID: 21356357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy.
    Arya R; Kedar V; Hwang JR; McDonough H; Li HH; Taylor J; Patterson C
    J Cell Biol; 2004 Dec; 167(6):1147-59. PubMed ID: 15596539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.
    Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C
    Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo.
    Willis MS; Ike C; Li L; Wang DZ; Glass DJ; Patterson C
    Circ Res; 2007 Mar; 100(4):456-9. PubMed ID: 17272810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
    Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
    J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo.
    Willis MS; Schisler JC; Li L; Rodríguez JE; Hilliard EG; Charles PC; Patterson C
    Circ Res; 2009 Jul; 105(1):80-8. PubMed ID: 19498199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rise above: muscle ring-finger-1 (MURF1) regulation of cardiomyocyte size and energy metabolism.
    Patterson C; Willis MS; Portbury A
    Trans Am Clin Climatol Assoc; 2011; 122():70-81. PubMed ID: 21686210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle ring finger 1 mediates cardiac atrophy in vivo.
    Willis MS; Rojas M; Li L; Selzman CH; Tang RH; Stansfield WE; Rodriguez JE; Glass DJ; Patterson C
    Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H997-H1006. PubMed ID: 19168726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
    Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
    Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
    Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
    Skurk C; Izumiya Y; Maatz H; Razeghi P; Shiojima I; Sandri M; Sato K; Zeng L; Schiekofer S; Pimentel D; Lecker S; Taegtmeyer H; Goldberg AL; Walsh K
    J Biol Chem; 2005 May; 280(21):20814-23. PubMed ID: 15781459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.
    Mearini G; Gedicke C; Schlossarek S; Witt CC; Krämer E; Cao P; Gomes MD; Lecker SH; Labeit S; Willis MS; Eschenhagen T; Carrier L
    Cardiovasc Res; 2010 Jan; 85(2):357-66. PubMed ID: 19850579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
    Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
    Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.
    Kedar V; McDonough H; Arya R; Li HH; Rockman HA; Patterson C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18135-40. PubMed ID: 15601779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.